


Anti-SAE Identifies a Subtype of Dermatomyositis

FDA Grants Octapharma 7-Year Market Exclusivity for Octagam 10%

FDA Approves IVIG to Treat Adults with Dermatomyositis

Case Report: A Rare But Severe Complication of Dermatomyositis

• By Lara C. Pullen, PhD
• By Akrithi Udupa, MD, Paul McIntosh, MD, Thomas J. Cummings, MD, & Lisa Criscione-Schreiber, MD, Med
• By Barrett Ford, MD, Chandana Shilpa Ravipati, DO, & Nirupa Patel, MD
• By Arthritis & Rheumatology
• By Kathy Holliman
Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.
Visit the official website for the American College of Rheumatology.
Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.